Home Applications 020981 Application 020981
Type NDA
Sponsor NOVARTIS Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 HYCAMTIN TOPOTECAN HYDROCHLORIDE CAPSULE;ORAL EQ 0.25MG BASE Yes No 002 HYCAMTIN TOPOTECAN HYDROCHLORIDE CAPSULE;ORAL EQ 1MG BASE Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N020981-001 HYCAMTIN TOPOTECAN HYDROCHLORIDE EQ 0.25MG BASE CAPSULE / ORAL RLD 2007-10-11 N020981-002 HYCAMTIN TOPOTECAN HYDROCHLORIDE EQ 1MG BASE CAPSULE / ORAL RLD, RS 2007-10-11
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 3 · 90 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 N020981-001 HYCAMTIN EQ 0.25MG BASE CAPSULE / ORAL RLD 2007-10-11 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N020981-002 HYCAMTIN EQ 1MG BASE CAPSULE / ORAL RLD, RS 2007-10-11 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N020981-001 HYCAMTIN EQ 0.25MG BASE CAPSULE / ORAL RLD 2007-10-11 c2088c7a36db…2026-10-15 13:18:30 2026-09 N020981-002 HYCAMTIN EQ 1MG BASE CAPSULE / ORAL RLD, RS 2007-10-11 c2088c7a36db…2026-09-14 22:38:34 2026-08 N020981-001 HYCAMTIN EQ 0.25MG BASE CAPSULE / ORAL RLD 2007-10-11 84e616aacf4f…2026-09-14 22:38:34 2026-08 N020981-002 HYCAMTIN EQ 1MG BASE CAPSULE / ORAL RLD, RS 2007-10-11 84e616aacf4f…2026-08-18 06:07:40 2026-07 N020981-001 HYCAMTIN EQ 0.25MG BASE CAPSULE / ORAL RLD 2007-10-11 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N020981-002 HYCAMTIN EQ 1MG BASE CAPSULE / ORAL RLD, RS 2007-10-11 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N020981-001 HYCAMTIN EQ 0.25MG BASE CAPSULE / ORAL RLD 2007-10-11 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N020981-002 HYCAMTIN EQ 1MG BASE CAPSULE / ORAL RLD, RS 2007-10-11 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020981-001 HYCAMTIN EQ 0.25MG BASE CAPSULE / ORAL RLD 2007-10-11 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020981-002 HYCAMTIN EQ 1MG BASE CAPSULE / ORAL RLD, RS 2007-10-11 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N020981-001 HYCAMTIN EQ 0.25MG BASE CAPSULE / ORAL RLD 2007-10-11 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N020981-002 HYCAMTIN EQ 1MG BASE CAPSULE / ORAL RLD, RS 2007-10-11 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020981-001 HYCAMTIN EQ 0.25MG BASE CAPSULE / ORAL RLD 2007-10-11 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020981-002 HYCAMTIN EQ 1MG BASE CAPSULE / ORAL RLD, RS 2007-10-11 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020981-001 HYCAMTIN EQ 0.25MG BASE CAPSULE / ORAL RLD 2007-10-11 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020981-002 HYCAMTIN EQ 1MG BASE CAPSULE / ORAL RLD, RS 2007-10-11 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020981-001 HYCAMTIN EQ 0.25MG BASE CAPSULE / ORAL RLD 2007-10-11 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020981-002 HYCAMTIN EQ 1MG BASE CAPSULE / ORAL RLD, RS 2007-10-11 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020981-001 HYCAMTIN EQ 0.25MG BASE CAPSULE / ORAL RLD 2007-10-11 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020981-002 HYCAMTIN EQ 1MG BASE CAPSULE / ORAL RLD, RS 2007-10-11 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020981-001 HYCAMTIN EQ 0.25MG BASE CAPSULE / ORAL RLD 2007-10-11 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020981-002 HYCAMTIN EQ 1MG BASE CAPSULE / ORAL RLD, RS 2007-10-11 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020981-001 HYCAMTIN EQ 0.25MG BASE CAPSULE / ORAL RLD 2007-10-11 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020981-002 HYCAMTIN EQ 1MG BASE CAPSULE / ORAL RLD, RS 2007-10-11 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N020981-001 HYCAMTIN EQ 0.25MG BASE CAPSULE / ORAL RLD 2007-10-11 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N020981-002 HYCAMTIN EQ 1MG BASE CAPSULE / ORAL RLD, RS 2007-10-11 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N020981-001 HYCAMTIN EQ 0.25MG BASE CAPSULE / ORAL RLD 2007-10-11 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N020981-002 HYCAMTIN EQ 1MG BASE CAPSULE / ORAL RLD, RS 2007-10-11 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N020981-001 HYCAMTIN EQ 0.25MG BASE CAPSULE / ORAL RLD 2007-10-11 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N020981-002 HYCAMTIN EQ 1MG BASE CAPSULE / ORAL RLD, RS 2007-10-11 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N020981-001 HYCAMTIN EQ 0.25MG BASE CAPSULE / ORAL RLD 2007-10-11 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N020981-002 HYCAMTIN EQ 1MG BASE CAPSULE / ORAL RLD, RS 2007-10-11 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N020981-001 HYCAMTIN EQ 0.25MG BASE CAPSULE / ORAL RLD 2007-10-11 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N020981-002 HYCAMTIN EQ 1MG BASE CAPSULE / ORAL RLD, RS 2007-10-11 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N020981-001 HYCAMTIN EQ 0.25MG BASE CAPSULE / ORAL RLD 2007-10-11 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N020981-002 HYCAMTIN EQ 1MG BASE CAPSULE / ORAL RLD, RS 2007-10-11 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N020981-001 HYCAMTIN EQ 0.25MG BASE CAPSULE / ORAL RLD 2007-10-11 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N020981-002 HYCAMTIN EQ 1MG BASE CAPSULE / ORAL RLD, RS 2007-10-11 5d02ea3f76ae…
Observed Orange Book patent history# Patent history page 2 of 2 · 70 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2019-09-15 20:21 UTC 2019-09 N020981-001 8158645 2024-12-10 Drug product 2012-05-11 b00525d2431f…2019-09-15 20:21 UTC 2019-09 N020981-002 8158645 2024-12-10 Drug product b00525d2431f…2019-07-19 19:46 UTC 2019-07 N020981-001 8158645 2024-12-10 Drug product 2012-05-11 ea99ee380514…2019-07-19 19:46 UTC 2019-07 N020981-002 8158645 2024-12-10 Drug product ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N020981-001 8158645 2024-12-10 Drug product 2012-05-11 6a51e52b5d6a…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N020981-002 8158645 2024-12-10 Drug product 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N020981-001 8158645 2024-12-10 Drug product 2012-05-11 1c564ffb4f44…2024-02-18 07:12 UTC 2024-02 N020981-002 8158645 2024-12-10 Drug product 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N020981-001 8158645 2024-12-10 Drug product 2012-05-11 ea1830bbd6c7…2023-12-20 04:57 UTC 2023-12 N020981-002 8158645 2024-12-10 Drug product ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N020981-001 8158645 2024-12-10 Drug product 2012-05-11 a72a2bbeb626…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N020981-002 8158645 2024-12-10 Drug product a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N020981-001 8158645 2024-12-10 Drug product 2012-05-11 9b2671bbb829…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N020981-002 8158645 2024-12-10 Drug product 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N020981-001 8158645 2024-12-10 Drug product 2012-05-11 a67488948f0b…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N020981-002 8158645 2024-12-10 Drug product a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N020981-001 8158645 2024-12-10 Drug product 2012-05-11 3f0d92c62455…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N020981-002 8158645 2024-12-10 Drug product 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N020981-001 8158645 2024-12-10 Drug product 2012-05-11 053a50430f4f…2023-05-13 08:27 UTC 2023-05 N020981-002 8158645 2024-12-10 Drug product 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N020981-001 8158645 2024-12-10 Drug product 2012-05-11 3bdfa0b2c4d7…2023-01-26 05:58 UTC 2023-01 N020981-002 8158645 2024-12-10 Drug product 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N020981-001 8158645 2024-12-10 Drug product 2012-05-11 3a93d1ddd44b…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N020981-002 8158645 2024-12-10 Drug product 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N020981-001 8158645 2024-12-10 Drug product 2012-05-11 f41ea6bd6efb…2022-10-28 04:53 UTC 2022-10 N020981-002 8158645 2024-12-10 Drug product f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N020981-001 8158645 2024-12-10 Drug product 2012-05-11 e64feba35796…2022-09-29 23:25 UTC 2022-09 N020981-002 8158645 2024-12-10 Drug product e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N020981-001 8158645 2024-12-10 Drug product 2012-05-11 cb3db0bc1861…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N020981-002 8158645 2024-12-10 Drug product cb3db0bc1861…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join HYCAMTIN TOPOTECAN Sandoz Inc b23b46f5-c276-47f5-8bbd-940680b3f579 2023-09-18 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (NDA): 020981 application number: NDA020981
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 10 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0078-0672 HYCAMTIN topotecan Novartis Pharmaceuticals Corporation NDA Current 0078-0672 HYCAMTIN topotecan Novartis Pharmaceuticals Corporation NDA Current 0078-0672 HYCAMTIN topotecan Novartis Pharmaceuticals Corporation NDA Current 0078-0672 HYCAMTIN topotecan Novartis Pharmaceuticals Corporation NDA Current 0078-0672 HYCAMTIN topotecan Novartis Pharmaceuticals Corporation NDA Current 0078-0673 HYCAMTIN topotecan Novartis Pharmaceuticals Corporation NDA Current 0078-0673 HYCAMTIN topotecan Novartis Pharmaceuticals Corporation NDA Current 0078-0673 HYCAMTIN topotecan Novartis Pharmaceuticals Corporation NDA Current 0078-0673 HYCAMTIN topotecan Novartis Pharmaceuticals Corporation NDA Current 0078-0673 HYCAMTIN topotecan Novartis Pharmaceuticals Corporation NDA Current
Documents# Document, Submission type, Date table Document Submission type Date 55453 SUPPL 2018-09-12 55391 SUPPL 2018-09-06 35783 SUPPL 2014-06-23 26372 SUPPL 2014-06-19 14081 SUPPL 2011-10-12 3930 SUPPL 2011-10-12 14080 SUPPL 2010-07-06 3929 SUPPL 2010-07-02 44634 ORIG 2009-01-15 21325 ORIG 2009-01-15 26371 ORIG 2007-10-22 14079 ORIG 2007-10-12